Confidence through proven and transparent methodology
IMS Market Prognosis combines historical data and macroeconomic indicators with the identification and evaluation of key future issues.
CREATING THE BASELINE – QUANTITATIVE PROJECTION
Initial baseline projections combine IMS market information with in-depth macroeconomic indicators to feed into IMS’s proven econometric model.
- 40 quarters of historical data by sector
- Estimates of unaudited market sectors
- 5 main macroeconomic indicators based on historical information
REFINE THE BASELINE – IDENTIFY, EVALUATE & QUANTIFY EVENTS
The baseline is refined and adjusted with IMS expertise and insight within each country. This is supplemented with extensive primary and secondary research among all key stakeholders in the industry, including government representatives, regulatory authorities, key opinion leaders, specialists, physicians, pharmacists, pharmaceutical companies and wholesalers.
Events are based on:
- Legislative changes
- Pricing system changes, price cuts
- Reimbursement status changes
- Healthcare budget constraints/cuts
- Cost-containment measures
- Generics competition
- Major new product launches
THE “EVENTED” FORECAST
IMS Market Prognosis presents 5-year country forecasts for:
- Retail and hospital
- Price and volume
- Total market sales
